Tamar I. de Vries

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

Steven H J Hageman, Lisa Pennells, Francisco Ojeda et al. · European Heart Journal · 2021 · 1.6K citations · Full text

Public Health, Health Sciences, Preventive Medicine +17

SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions

Tamar I. de Vries, Marie Therese Cooney, Randi Selmer et al. · European Heart Journal · 2021 · 589 citations · Full text

Medicine, Geriatric Medicine, Aging +16

Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability

Glen R. Monroe, G. W. J. Frederix, Sanne M. C. Savelberg et al. · Genetics in Medicine · 2016 · 185 citations · Full text

Life Sciences, Genetics, Pediatrics +16

Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial

Tamar I. de Vries, John W. Eikelboom, Jackie Bosch et al. · European Heart Journal · 2019 · 39 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD Trial

Tamar I. de Vries, Jannick A N Dorresteijn, Yolanda van der Graaf et al. · Diabetes Care · 2019 · 34 citations · Full text

Medicine, Chronic Disease Control, Chronic Disease Prevention +17